Abstract

A simple and cost-effective method was developed to determine fluorouracil (5-FU) and phenobarbital (PHB) in human body fluids. A coating based on a zeolitic imidazole framework-67 (ZIF-67) template cobalt nanoporous carbon (Co-NPC) was synthesized by one-step carbonization of ZIF-67 without using any other carbon precursors in the present study. The prepared Co-NPC was then fabricated on the surface of a prepared stir bar to be used as stir bar sorptive extraction (SBSE) method. The extracted analytes were then analyzed via high performance liquid chromatography-ultraviolet detection (HPLC-UV). Plackett–Burman design was employed for screening the experimental factors. The effective factors were then optimized using Central Composite Design (CCD). Under the optimum conditions, limits of detections (LODs) of 5-FU were 0.36, 0.41 and 1.2 μg L−1 in water, urine and plasma samples, respectively. Limits of quantifications (LOQs) were also 1.2, 1.3 and 4.5 μg L−1 in water, urine and plasma samples, respectively. Relative standard deviations (RSDs) at a spiked concentration of 10 μg L−1 were 8.1, 7.9 and 8.6% (as intra-day RSD) in water, urine and plasma samples, respectively. The linear dynamic ranges (LDRs) were in the range of 1–200 μg L−1. Moreover, LODs of PHB were 0.21, 0.32 and 1.4 μg L−1 in water, urine and plasma samples, respectively. LOQs were also 0.9, 1.1 and 4.6 μg L−1 in water, urine and plasma samples, respectively. Relative standard deviations (RSDs) at a spiked concentration of 10 μg L−1 were 6.3, 6.5 and 6.9% (as intra-day RSD) in water, urine and plasma samples, respectively. The linear dynamic ranges (LDRs) were in the range of 1–500 μg L−1. The applicability of the method was investigated by the extraction and determination of the target analytes in different biological fluids including urine and plasma samples.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call